Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

30.57 -0.11 (-0.36%)

Streaming Delayed Price Updated: 2:47 PM EDT, May 22, 2026 Add to My Watchlist

Price and Volume

Volume	680,080
Open	30.58
Bid (Size)	30.53 (100)
Ask (Size)	30.58 (100)
Prev. Close	30.68
Today's Range	30.29 - 30.82
52wk Range	22.96 - 43.15
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Stocks That Could Realistically Double by 2030 ↗

Today 3:35 EDT

Long-time shareholders are already pretty satisfied with these companies, but there might be even more upside ahead.

Via The Motley Fool

Could Viking Therapeutics Be the Next Eli Lilly? ↗

May 21, 2026

Demand for weight loss drugs may fuel growth for more than one player.

Via The Motley Fool

Performance

YTD	-13.7%	-13.7%
1 Month	-9.6%	-9.6%
3 Month	-1.7%	-1.7%
6 Month	-10.8%	-10.8%
1 Year	+12.2%	+12.2%

More News

Best Weight Loss Drug Stocks to Buy in 2026 ↗

May 20, 2026

Via The Motley Fool

Viking Therapeutics (NASDAQ:VKTX) Stock Holds Steady After Q1 2026 Earnings Miss on Higher Phase 3 Spending ↗

April 29, 2026

Via Chartmill

Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party ↗

May 18, 2026

Via The Motley Fool

Eli Lilly Stock: Next Stop $2,000? ↗

May 18, 2026

Via The Motley Fool

Should Eli Lilly Investors Worry About Its Newest Rival -- From Within? ↗

May 14, 2026

Via The Motley Fool

Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities

May 13, 2026

Via Investor Brand Network

InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

May 13, 2026

Via Investor Brand Network

Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months ↗

May 04, 2026

Via The Motley Fool

Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities

May 13, 2026

From BioMedWire

Via GlobeNewswire

Eli Lilly Just Announced Fantastic News for Shareholders ↗

May 04, 2026

Via The Motley Fool

Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge ↗

May 01, 2026

Via MarketBeat

Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead? ↗

April 30, 2026

Via The Motley Fool

This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street ↗

April 26, 2026

Via The Motley Fool

Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? ↗

April 25, 2026

Via The Motley Fool

The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

April 23, 2026

From Equity Insider

Via GlobeNewswire

Better Long-Term Buy: Eli Lilly or Viking Therapeutics? ↗

April 17, 2026

Via The Motley Fool

Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026? ↗

April 17, 2026

Via The Motley Fool

Better Healthcare Stock to Own in a Recession: Defensive or Growth? ↗

April 04, 2026

Via The Motley Fool

Where Will Viking Therapeutics Stock Be in 10 Years? ↗

April 03, 2026

Via The Motley Fool

The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets

April 03, 2026

Via MarketMinute

Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring

April 02, 2026

Via MarketMinute

2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More ↗

March 31, 2026

Via The Motley Fool

1 Reason This Biotech Stock Could Triple Before Year-End ↗

March 29, 2026

Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 30.57

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 05/22/26 02:47 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.04B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.